Smith & Nephew, the medical equipment specialist reports group revenue for full year 2017 of $4,765m, an increase of 3% on an underlying basis, in line with guidance.
The company also shows that full year dividend was up 14% to 35.0¢ per share.
Commenting on the latest figures, Olivier Bohuon, Chief Executive Officer of Smith & Nephew, said: "We delivered on our promises to improve the top and bottom line in 2017. Our Knee Implants franchise delivered a standout performance and we returned to double-digit growth in the Emerging Markets."
He added: “Our healthy balance sheet, good cash generation and increased dividend demonstrate the robust foundations underpinning our business. "In 2018 I expect Smith & Nephew to build on 2017 by delivering another year of improved performance driven by our strong product portfolio and pipeline of innovative products.